Hospira does not sell the Symbiq system anymore, but it's still available for purchase from some third-party retailers and the FDA warns against buying it. The network vulnerability would "allow an unauthorized user to control the device and change the dosage the pump delivers, which could lead to over- or under-infusion of critical patient therapies," the organization says.

This safety alert marks the FDA's entrance into cybersecurity territory. Recently, corporate giants GM, Fiat Chrysler, Anthem insurance and United Airlines (to name a few) have faced reported hacks. Last month, the US Office of Personnel Management was the subject of a cyberattack that put the social security information of 21.5 million Americans at risk. Welcome to the digital age.